RECALL DATABASE

Semaglutide Recall: Nomida Lot 241113 and Lot 250103

Announced 2026-03-11 · FDA

The FDA recall affects New Life Pharma LLC Semaglutide Inj, 2 mg, Sterile Multi-Dose Vial, Rx only, distributed in Ohio, due to lack of assurance of sterility. Affected lots are Lot 241113 (exp 11/30/2026) and Lot 250103 (exp 1/31/2027); total 820 vials were involved. No corrective action is specified in the provided information.

BrandNew Life Pharma LLC
ProductSemaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07.
ReasonLack of Assurance of Sterility
Severitymoderate
Units affected2
DistributionOH
AgencyFDA

WHAT YOU SHOULD DO

  1. Do not use any recalled Semaglutide vials (Lot 241113 or Lot 250103).
  2. Contact your healthcare provider or dispensing pharmacy for guidance and replacement options.
  3. Return or dispose of the recalled vials per the pharmacy or manufacturer’s instructions.
  4. If you have experienced problems, report them to your healthcare provider or FDA MedWatch.

How to identify the recalled item

Lot / date codesLot 241113, Exp Date 11/30/2026 & Lot 250103, Exp Date 1/31/2027
Lot / date codesLot 240903, exp 9/30/2026

These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.

Other semaglutide recalls

See every semaglutide recall →

This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.